These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 32350732)

  • 21. KMT2A (MLL) rearrangements observed in pediatric/young adult T-lymphoblastic leukemia/lymphoma: A 10-year review from a single cytogenetic laboratory.
    Peterson JF; Baughn LB; Pearce KE; Williamson CM; Benevides Demasi JC; Olson RM; Goble TA; Meyer RG; Greipp PT; Ketterling RP
    Genes Chromosomes Cancer; 2018 Nov; 57(11):541-546. PubMed ID: 30203571
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent Developments and Evolving Therapeutic Strategies in KMT2A-Rearranged Acute Leukemia.
    Yin L; Wan L; Zhang Y; Hua S; Shao X
    Cancer Med; 2024 Oct; 13(20):e70326. PubMed ID: 39428967
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TGFβ1 synergizes with FLT3 ligand to induce chemoresistant quiescence in acute lymphoblastic leukemia with MLL gene rearrangements.
    Tamai M; Furuichi Y; Kasai S; Ando N; Harama D; Goi K; Inukai T; Kagami K; Abe M; Ichikawa H; Sugita K
    Leuk Res; 2017 Oct; 61():68-76. PubMed ID: 28917156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The CDK9 Inhibitor Dinaciclib Exerts Potent Apoptotic and Antitumor Effects in Preclinical Models of MLL-Rearranged Acute Myeloid Leukemia.
    Baker A; Gregory GP; Verbrugge I; Kats L; Hilton JJ; Vidacs E; Lee EM; Lock RB; Zuber J; Shortt J; Johnstone RW
    Cancer Res; 2016 Mar; 76(5):1158-69. PubMed ID: 26627013
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Network-based expression analysis reveals key genes related to glucocorticoid resistance in infant acute lymphoblastic leukemia.
    Mousavian Z; Nowzari-Dalini A; Stam RW; Rahmatallah Y; Masoudi-Nejad A
    Cell Oncol (Dordr); 2017 Feb; 40(1):33-45. PubMed ID: 27798768
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distinct Responses to Menin Inhibition and Synergy with DOT1L Inhibition in
    Adriaanse FRS; Schneider P; Arentsen-Peters STCJM; Fonseca AMND; Stutterheim J; Pieters R; Zwaan CM; Stam RW
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892207
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunobiological diversity in infant acute lymphoblastic leukemia is related to the occurrence and type of MLL gene rearrangement.
    Jansen MW; Corral L; van der Velden VH; Panzer-Grümayer R; Schrappe M; Schrauder A; Marschalek R; Meyer C; den Boer ML; Hop WJ; Valsecchi MG; Basso G; Biondi A; Pieters R; van Dongen JJ
    Leukemia; 2007 Apr; 21(4):633-41. PubMed ID: 17268512
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cellular drug sensitivity in MLL-rearranged childhood acute leukaemia is correlated to partner genes and cell lineage.
    Palle J; Frost BM; Forestier E; Gustafsson G; Nygren P; Hellebostad M; Jonsson OG; Kanerva J; Schmiegelow K; Larsson R; Lönnerholm G;
    Br J Haematol; 2005 Apr; 129(2):189-98. PubMed ID: 15813846
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of RAS mutations in MLL-rearranged leukaemia: A path to intervention?
    Mansur MB; Ford AM; Emerenciano M
    Biochim Biophys Acta Rev Cancer; 2017 Dec; 1868(2):521-526. PubMed ID: 29056538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cryptic and atypical KMT2A-USP2 and KMT2A-USP8 rearrangements identified by mate pair sequencing in infant and childhood leukemia.
    Blackburn PR; Smadbeck JB; Znoyko I; Webley MR; Pitel BA; Vasmatzis G; Xu X; Greipp PT; Hoppman NL; Ketterling RP; Baughn LB; Lindsey KG; Schandl CA; Wolff DJ; Peterson JF
    Genes Chromosomes Cancer; 2020 Jul; 59(7):422-427. PubMed ID: 32196814
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unraveling the cellular origin and clinical prognostic markers of infant B-cell acute lymphoblastic leukemia using genome-wide analysis.
    Agraz-Doblas A; Bueno C; Bashford-Rogers R; Roy A; Schneider P; Bardini M; Ballerini P; Cazzaniga G; Moreno T; Revilla C; Gut M; Valsecchi MG; Roberts I; Pieters R; De Lorenzo P; Varela I; Menendez P; Stam RW
    Haematologica; 2019 Jun; 104(6):1176-1188. PubMed ID: 30679323
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Haploidentical peripheral blood stem cell transplantation without irradiation or busulfan after reduced-intensity conditioning for KMT2A(MLL)-rearranged infant B-cell precursor acute lymphoblastic leukemia: Report of two cases.
    Yoshimi A; Kato K; Hosaka S; Suzuki R; Fukushima H; Nakao T; Kobayashi C; Fukushima T; Koike K; Sumazaki R; Tsuchida M
    Pediatr Transplant; 2017 Jun; 21(4):. PubMed ID: 28332262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcome of recurrent or refractory acute lymphoblastic leukemia in infants with MLL gene rearrangements: A report from the Japan Infant Leukemia Study Group.
    Tomizawa D; Koh K; Hirayama M; Miyamura T; Hatanaka M; Saikawa Y; Ishii E
    Pediatr Blood Cancer; 2009 Jul; 52(7):808-13. PubMed ID: 19229974
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytosine arabinoside-metabolizing enzyme genes are underexpressed in children with MLL gene-rearranged acute lymphoblastic leukemia.
    Mata JF; Scrideli CA; Queiroz RP; Mori BO; Emerenciano M; Pombo-de-Oliveira MS; Tone LG
    Braz J Med Biol Res; 2006 Nov; 39(11):1417-23. PubMed ID: 17146554
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bilateral ovarian B-lineage lymphoblastic lymphoma with MLL gene rearrangement: a novel case in infancy.
    Larish AM; Dolan M; Casey T; Perkins JL
    J Pediatr Hematol Oncol; 2015 May; 37(4):e215-7. PubMed ID: 25493458
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insights from clinical studies into the role of the MLL gene in infant and childhood leukemia.
    Chowdhury T; Brady HJ
    Blood Cells Mol Dis; 2008; 40(2):192-9. PubMed ID: 17905612
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    Britten O; Ragusa D; Tosi S; Kamel YM
    Cells; 2019 Oct; 8(11):. PubMed ID: 31671855
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MLL-rearranged acute myeloid leukemia: Influence of the genetic partner in allo-HSCT response and prognostic factor of MLL 3' region mRNA expression.
    Burillo-Sanz S; Morales-Camacho RM; Caballero-Velázquez T; Carrillo E; Sánchez J; Pérez-López O; Pérez de Soto I; González Campos J; Prats-Martín C; Bernal R; Vargas MT
    Eur J Haematol; 2018 May; 100(5):436-443. PubMed ID: 29384595
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CN470 is a BET/CBP/p300 multi-bromodomain inhibitor and has an anti-tumor activity against MLL-rearranged acute lymphoblastic leukemia.
    Imayoshi N; Yoshioka M; Tanaka K; Yang SM; Akahane K; Toda Y; Hosogi S; Inukai T; Okada S; Maloney DJ; Nakahata T; Takita J; Kato I; Ashihara E
    Biochem Biophys Res Commun; 2022 Jan; 590():49-54. PubMed ID: 34971957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Small-molecule inhibitor of AF9/ENL-DOT1L/AF4/AFF4 interactions suppresses malignant gene expression and tumor growth.
    Wu F; Nie S; Yao Y; Huo T; Li X; Wu X; Zhao J; Lin YL; Zhang Y; Mo Q; Song Y
    Theranostics; 2021; 11(17):8172-8184. PubMed ID: 34373735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.